Israel Englander Cerevel Therapeutics Holdings, Inc. Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 101,400 shares of CERE stock, worth $4.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,400
Previous 1,111,112
90.87%
Holding current value
$4.13 Million
Previous $47.1 Million
90.9%
% of portfolio
0.0%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CERE
# of Institutions
227Shares Held
150MCall Options Held
939KPut Options Held
961K-
Bain Capital Investors LLC Boston, MA65.7MShares$2.68 Billion61.94% of portfolio
-
Perceptive Advisors LLC New York, NY10.8MShares$440 Million9.58% of portfolio
-
Avoro Capital Advisors LLC New York, NY7.56MShares$308 Million3.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.46MShares$304 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$222 Million0.01% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Market Cap $6.35B
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...